HEALTH OF WOMAN. 2018.2(128):27–30

Prilepskaya N., Dovlethanova E. R.
National Medical Research Center of Obstetrics, Gynecology and Perinatology
them. V.I. Kulakov of the Ministry of Health of Russia
Medical advice. – No. 13, 2017

The premenstrual syndrome (PMS) is a pathological symptom that significantly reduces the quality of a woman’s life. The etiology and pathogenesis to date have not been sufficiently studied, but the diagnosis, treatment and prevention that are to be complied with have been identified. The treatment of the PMS should be differentiated, taking into account the overall and reproductive health of the woman, the concomitant diseases, the degree of severity of ICP, the portability of therapy, etc.
Key words: Premenstrual syndrome, PMS, quality of life, virgin bush, Vitex Agnus-castus, Mastodynon^®, Cyclodynon^®.

REFERENCES

1. Prilepskaya VN, Ledina AV, Tagiyeva AY, Revazova FS. 2006. Vitex agnus castus: Successful treatment of moderate to severe premenstrual syndrome. Maturitas. 55(SuppLement 1):55–63.

2. Aganezova NV. 2011. Predmenstrualnyiy sindrom: biologicheskie i psihosotsialnyie prediktoryi patogeneza, klinika, obosnovanie kompleksnoy terapii. Doktorskaya dissertatsiya: 372.

3. Ledina AV. 2014. Predmenstrualnyiy sindrom: epidemiologiya, klinika, diagnostika i lechenie. Avtoreferat doktorskoy dissertatsii.

4. Management of premenstrual syndrome. Green-top Guideline 48, BJOG. 2016. DOI: 10.1111/1471- 0528.14260. November 2016, RoyaL College of Obstetricians and Gynaecologists. NICE.

5. Zamani M, Neghab N, Torabian S. 2012. Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome. Acta MedIran. 50:101–6. PMid:22359078

6. Prilepskaya VN, Mezhevitinova EA, Sasunova RA, Ivanova EV, Letunovskaya AB, Nabieva KR. 2012. Rezultatyi klinicheskogo primeneniya preparata, soderzhaschego drospirenon, u zhenschin s tyazheloy formoy predmenstrualnogo sindroma. Akusherstvo i ginekologiya 2:81–85.

7. Mahmoud Rafieian-Kopaei and Mino Movahedi. 2017, January. Systematic Review of Premenstrual, Postmenstrual and Infertility Disorders of Vitex Agnus Castus. Electronic Physician. 9(Issue 1):3685–3689. https://doi.org/10.19082/3685; PMid:28243425 PMCid:PMC5308513

8. Sarrafchi A, Bahmani M, Shirzad H, Rafieian-Kopaei M. 2016. Oxidative stress and Parkinson’s disease: New hopes in treatment with herbal antioxidants. Curr Pharm Des. 22(2):238-46. doi: 10.2174/13816 12822666151112151653.

9. Miraj S, Rafieian-Kopaei M, Kiani S. 2016. MeLissa officinalis L: A Review Study With an Antioxidant Prospective. J Evid Based Complementary Altern Med. https://doi.org/10.1177/2156587216663433.

10. Baharvand-Ahmadi B, Bahmani M, Tajeddini P, Rafieian-Kopaei M, Naghdi N. 2016. An ethnobotanical study of medicinal plants administered for the treatment of hypertension. J Renal Inj Prev. 5(3):123-8. https://doi.org/10.15171/jrip.2016.26.

11. Rouhi-Boroujeni H, Rouhi-Boroujeni H, Gharipour M, Mohammadizadeh F, Ahmadi S, Rafieian-Kopaei M. 2015. Systematic review on safety and drug interaction of herbal therapy in hyperlipidemia: a guide for internist. Acta Biomed. 86(2):130–6. PMid:26422426

12. Khalilzadeh E, Vafaei Saiah G, Hasannejad H, Ghaderi A, Ghaderi S, Hamidian G et al. 2015. Antinociceptive effects, acute toxicity and chemical composition of Vitex agnus-castus essential oil. Avicenna J Phytomed. 5(3):218–30. PMid:26101755 PMCid:PMC4469960

13. He Z, Chen R, Zhou Y, Geng L, Zhang Z, Chen S et al. 2009. Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multi­center placebo controlled study in China. Maturitas. 63(1):99-103. doi: 10.1016/j.maturitas. 2009.01.006.

14. Jang SH, Kim DI, Choi MS. 2014. Effects and treatment methods of acupuncture and herbal medicine for premenstrual syndrome/premenstrual dysphoric disorder: systematic review. BMC Complement Altern Med. 14:11. https://doi.org/10.1186/1472-6882-14-11.

15. Weisz G, Knaapen L. 2009. Diagnosing and treating premenstrual syndrome in five western nations. Soc Sci Med. 68(8):1498-505. doi: 10.1016/j.socsci- med.2009.01.036.

16. Atmaca M, Kumru S, Tezcan E. 2003. Fluoxetine versus Vitex agnus castus extract in the treatment of pre­menstrual dysphoric disorder. Hum Psychopharmacol. 18(3):191-5. https://doi.org/10.1002/hup.470.

17. Ma L, Lin S, Chen R, Zhang Y, Chen F, Wang X. 2010. Evaluating therapeutic effect in symptoms of moderate to – severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Aust N Z J Obstet Gynaecol. 50(2):189-93. https://doi.org/10.1111/j.1479-828X.2010.01137.x.

18. Kelderhouse K1, Taylor JS. 2013, Aug-Sep. A review of treatment and management modalities for premenstrual dysphoric disorder. Nurs Womens Health. 17(4):294-305. https://doi.org/10.1111/1751-486X.12048.

19. Birgit M Dietz, Atieh Hajirahimkhan, Tareisha L Dunlap and Judy L. 2016, Oct. Botanicals and Their Bioactive Phytochemicals for Women’s Health. Pharmacol Rev. 68(4):1026–1073. https://doi.org/10.1124/pr.115.010843; PMid:27677719 PMCid:PMC5050441

20. Rafieian-Kopaei M, Saki K, Bahmani M, Ghafourian S, Sadeghifard N, Taherikalani M. 2015. Listeriosis Phytotherapy: A Review Study on the Effectiveness of Iranian Medicinal Plants in Treatment of Listeriosis. J Evid Based Complementary Altern Med. https://doi.org/10.1177/2156587215621460.

21. Diana van Die M, Henry G Burger, Helena J Teede, Kerry M Bone. 2013. Vitex agnus-castus Extracts for Female Reproductive Disorders: A Systematic Review of Clinical Trials. Women’s Health. Planta Med. 79(07):562–575. PMid:23136064

22. Bahmani M, Sarrafchi A, Shirzad H, Rafieian-Kopaei M. 2016. Autism: Pathophysiology and Promising Herbal Remedies. Curr Pharm Des. 22(3):277-85. https://doi.org/10.2174/1381612822666151112151529.

23. Ambrosini A, Di Lorenzo C, Coppola G, Pierelli F. 2013. Use of Vitex agnus-castus in migrainous women with premenstrual syndrome: an open-label clinical observation. Acta Neurol Psychiatr Belg. 113(1):25-9. https://doi.org/10.1007/s13760-012-0111-4.

24. Webster DE, He Y, Chen SN, Pauli GF, Farnsworth NR, Wang ZJ. 2011. Opioidergic mechanisms underlying the actions of Vitex agnus-castus L. Biochem pharmacol. 81(1):170-7. doi: 10.1016/j. bcp.2010.09.013.

25. van Die MD, Bone KM, Burger HG, Reece JE, Teede HJ. 2009. Effects of a combination of Hypericum perforatum and Vitex agnus-castus on PMS-like symptoms in late-perimenopausal women: findings from a subpopulation analysis. J Altern Complement Med. 15(9):1045-8. https://doi.org/10.1089/acm.2008.0539.

26. Royal College of Obstetricians and Gynaecologists/ NAPS Guidelines on Guidelines on Premenstrual Syndrom. 01/12/2016.

27. Marjoribanks J, Brown J, O’Brien PM, Wyatt K. 2013, Jun 7. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 6:CD001396. https://doi.org/10.1002/14651858. CD001396.pub3.

28. Upchurch DM, Chyu L, Greendale GA, Utts J, Bair YA, Zhang G, Gold EB. 2007. Complementary and alternative medicine use among American women: findings from The National Health Interview Survey, 2002. J Women’s Health (Larchmt). 16:102–113. https://doi.org/10.1089/jwh.2006.M074; PMid:17324101

29. Zamani M, Neghab N, Torabian S. 2012. Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome. Acta Med Iran. 50(2):101–6. PMid:22359078

30. Ledina AV, Prilepskaya VN. 2015. Drospirenonsoderzhaschiy kontratseptiv: lechebnyie i profilakticheskie aspektyi primeneniya. Ginekologiya. 17(1):25–29.

31. Lauritzen C, Reuter HD, Repges R, Böhnert KJ, Schmidt U. 1997. Treatment of premenstrual tension syndrome with Vitex agnus castus controlled, double­blind study versus pyridoxine. Phytomedicine. 4(3):183-9. https://doi.org/10.1016/S0944-7113(97)80066-9.

32. Andrade C. 2016, Jul-Sep. Premenstrual dysphoric disorder: General overview, treatment strategies, and focus on sertraline for symptom-onset dosing. Indian J Psychiatry. 58(3):329-331. https://doi.org/10.4103/0019-5545.192014.

33. Ryu A, Kim TH. 2015, Dec. Premenstrual syndrome: A mini review. Maturitas. 82(4):436-40. https://doi.org/10.1016/j.maturitas.2015.08.010. Epub 2015 Aug 28.